Drug-Induced Acute Coronary Syndrome: A New Cardiovascular Concern With Immune Checkpoint Inhibitors and the Need for a Prospective Registry

Can J Cardiol. 2020 Apr;36(4):455-456. doi: 10.1016/j.cjca.2020.02.001. Epub 2020 Feb 8.

Authors

Waleed Alhumaid¹, D Ian Paterson²

Affiliations

¹ Division of Cardiology, Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada.
² Division of Cardiology, Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada. Electronic address: [email protected].

PMID: 32146066
DOI: 10.1016/j.cjca.2020.02.001

No abstract available

Publication types

Editorial
Comment

MeSH terms

Acute Coronary Syndrome*
Humans
Pharmacovigilance
Prospective Studies
Registries